Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Five Best And Worst Performing Healthcare Stocks In December 2022
Article By:
ValueWalk
Sunday, January 22, 2023 1:40 PM EDT
Multiple factors are expected to help the healthcare industry overcome inflationary pressures. If you are looking to invest in this sector, then to help you select, here are the five best and worst performing healthcare stocks in December 2022.
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke, And Ultragenyx
Article By:
Benzinga
Sunday, June 14, 2020 3:13 PM EDT
Biotech stocks came under pressure along with the broader market in the week that ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in the global markets.
In this article: MRK, EVOK, RARE, EPZM Also: AZN, GILD, BMY, SNY, RPRX, CELG, PRQR, NBRV, CBIO, UROV, CNTG
Building Products Maker Azek Surges In Debut
Article By:
The Fly
Sunday, June 14, 2020 2:18 PM EDT
After opening higher, building products maker Azek ended its first trading day up over 18%. The company raised about $765 million in the biggest initial public offering of the week.
In this article: RNA Also: BAC, GS, WFC, VXX, JEF, TREX, CS, LLY, COWN, SIVBQ, JPM, MS, EVR, RPRX, ADCT
Biotech Digest – XENT Gets FDA Approval, AGN Announces Acquisition, IONS Licenses Product
Article By:
KKD Healthcare Analytics
Tuesday, December 12, 2017 10:26 AM EDT
Intersect ENT Inc. reported the FDA approval for its SINUVA implant, designed to be used for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.